Assessment of subclinical diabetic cardiomyopathy by speckle‐tracking imaging

Ioan‐Alexandru Minciună,Olga Hilda Orășan,Iulia Minciună,Andrada‐Luciana Lazar,Adela Viviana Sitar‐Tăut,Monica Oltean,Raluca Tomoaia,Mihai Puiu,Dan‐Andrei Sitar‐Tăut,Dana Pop,Angela Cozma
DOI: https://doi.org/10.1111/eci.13475
2021-01-04
European Journal of Clinical Investigation
Abstract:<p>First reported in 1972, diabetic cardiomyopathy is defined as ventricular dysfunction in the absence of hypertension, coronary artery disease, congenital or valvular heart disease. Diagnosing diabetic cardiomyopathy from its subclinical stages is essential in order to prevent progression to the overt form of the disease. Speckle‐tracking echocardiography is a relatively new technique that can assess cardiac dysfunction from its subclinical stages. Diastolic dysfunction is traditionally believed to be the first subclinical manifestation of diabetic cardiomyopathy, leading to systolic dysfunction and then overt heart failure. However, in the last few years, several studies suggested that systolic subclinical dysfunction measured by speckle‐tracking echocardiography may appear ahead of diastolic dysfunction. In this review, the main endpoint is to show whether subclinical myocardial systolic dysfunction appears ahead of diastolic dysfunction and the implication this may have on the evolution and management of diabetic cardiomyopathy.</p>
medicine, general & internal, research & experimental
What problem does this paper attempt to address?